Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Roshana Saghafian Larijani
Institution:
Tehran University of Medical Sciences
Observed institutions:
University of Tehran,
Tehran University of Medical Sciences
ORCID:
0009-0002-4516-8264
Observed ORCID:
0009-0002-4516-8264
OpenAlex ID:
A5020928087
Current status of transarterial chemoembolization (TACE) agents in hepatocellular carcinoma treatment
2022
·
Roshana Saghafian Larijani
, Nazanin Shabani Ravari
, et al.
·
Journal of Drug Delivery Science and Technology
·
20
The impact of socially accountable health professional education: Systematic review
2022
·
Soheila Mahdavynia
, Samaneh Saghafian Larijani
, et al.
·
Journal of Family Medicine and Primary Care
·
18
Engineered PLGA microspheres for extended-release of naltrexone: in vitro, in vivo , and IVIVR
2023
·
Maryam Ghareh Sheikhlou
, Nazanin Shabani Ravari
, et al.
·
Pharmaceutical Development and Technology
·
8
Comparison of the outcomes of normal vaginal delivery with and without spinal anesthesia in mothers admitted to the maternity ward of Firoozabadi Hospital
2022
·
Samaneh Saghafian Larijani
, Maryam Niksolat
, et al.
·
Journal of Family Medicine and Primary Care
·
4
Adverse side effects of maternal levothyroxine consumption in pregnant women with subclinical hypothyroidism: a systematic review study
2025
·
Samaneh Saghafian Larijani
, Hosna Mirfakhraee
, et al.
·
Journal of Parathyroid Disease
·
1
PDF
Show more works
View as search
Works count:
5
Citation count:
51
H-index:
4
I10-index:
2
Year
Topic
Type